SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (22031)6/9/1998 11:32:00 PM
From: smh  Read Replies (1) of 32384
 
It is difficult to argue with the point of fact that one can buy the same share of LGND today - at the same price - as someone else who did so two years ago.

However, I suspect we all agree that biotech (including LGND) is undervalued. Based on your comment that you like the company and are poised to invest when the time is right, one might infer that you recognize the intrinsic value which Robinson has (hopefully) built over the last couple of years. So, are you waiting more for Robinson to change priorities or for the market to recognize LGND's value ?

Given the environment in which biotechs have existed, what should Robinson have done differently? I am sincerely and keenly interested in your thoughts on this point.

Regards

smh
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext